These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

325 related articles for article (PubMed ID: 21871373)

  • 1. A double-blind, placebo-controlled study of risperidone for the treatment of adolescents and young adults with anorexia nervosa: a pilot study.
    Hagman J; Gralla J; Sigel E; Ellert S; Dodge M; Gardner R; O'Lonergan T; Frank G; Wamboldt MZ
    J Am Acad Child Adolesc Psychiatry; 2011 Sep; 50(9):915-24. PubMed ID: 21871373
    [TBL] [Abstract][Full Text] [Related]  

  • 2. A placebo-controlled pilot study of adjunctive olanzapine for adolescents with anorexia nervosa.
    Kafantaris V; Leigh E; Hertz S; Berest A; Schebendach J; Sterling WM; Saito E; Sunday S; Higdon C; Golden NH; Malhotra AK
    J Child Adolesc Psychopharmacol; 2011 Jun; 21(3):207-12. PubMed ID: 21663423
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Intranasal oxytocin as an adjunct to risperidone in patients with schizophrenia : an 8-week, randomized, double-blind, placebo-controlled study.
    Modabbernia A; Rezaei F; Salehi B; Jafarinia M; Ashrafi M; Tabrizi M; Hosseini SM; Tajdini M; Ghaleiha A; Akhondzadeh S
    CNS Drugs; 2013 Jan; 27(1):57-65. PubMed ID: 23233269
    [TBL] [Abstract][Full Text] [Related]  

  • 4. A multicenter, randomized, double-blind, placebo-controlled, 16-week study of adjunctive aripiprazole for schizophrenia or schizoaffective disorder inadequately treated with quetiapine or risperidone monotherapy.
    Kane JM; Correll CU; Goff DC; Kirkpatrick B; Marder SR; Vester-Blokland E; Sun W; Carson WH; Pikalov A; Assunção-Talbott S
    J Clin Psychiatry; 2009 Oct; 70(10):1348-57. PubMed ID: 19906340
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A double-blind pilot study of risperidone in the treatment of conduct disorder.
    Findling RL; McNamara NK; Branicky LA; Schluchter MD; Lemon E; Blumer JL
    J Am Acad Child Adolesc Psychiatry; 2000 Apr; 39(4):509-16. PubMed ID: 10761354
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Rapid antimanic effect of risperidone monotherapy: a 3-week multicenter, double-blind, placebo-controlled trial.
    Hirschfeld RM; Keck PE; Kramer M; Karcher K; Canuso C; Eerdekens M; Grossman F
    Am J Psychiatry; 2004 Jun; 161(6):1057-65. PubMed ID: 15169694
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Risperidone for the treatment of acute mania in children and adolescents with bipolar disorder: a randomized, double-blind, placebo-controlled study.
    Haas M; Delbello MP; Pandina G; Kushner S; Van Hove I; Augustyns I; Quiroz J; Kusumakar V
    Bipolar Disord; 2009 Nov; 11(7):687-700. PubMed ID: 19839994
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Does fluoxetine augment the inpatient treatment of anorexia nervosa?
    Attia E; Haiman C; Walsh BT; Flater SR
    Am J Psychiatry; 1998 Apr; 155(4):548-51. PubMed ID: 9546003
    [TBL] [Abstract][Full Text] [Related]  

  • 9. A randomized, double-blind, placebo-controlled study of risperidone maintenance treatment in children and adolescents with disruptive behavior disorders.
    Reyes M; Buitelaar J; Toren P; Augustyns I; Eerdekens M
    Am J Psychiatry; 2006 Mar; 163(3):402-10. PubMed ID: 16513860
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Celecoxib as adjunctive treatment to risperidone in children with autistic disorder: a randomized, double-blind, placebo-controlled trial.
    Asadabadi M; Mohammadi MR; Ghanizadeh A; Modabbernia A; Ashrafi M; Hassanzadeh E; Forghani S; Akhondzadeh S
    Psychopharmacology (Berl); 2013 Jan; 225(1):51-9. PubMed ID: 22782459
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Olanzapine in the treatment of low body weight and obsessive thinking in women with anorexia nervosa: a randomized, double-blind, placebo-controlled trial.
    Bissada H; Tasca GA; Barber AM; Bradwejn J
    Am J Psychiatry; 2008 Oct; 165(10):1281-8. PubMed ID: 18558642
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Are antipsychotics effective for the treatment of anorexia nervosa? Results from a systematic review and meta-analysis.
    Kishi T; Kafantaris V; Sunday S; Sheridan EM; Correll CU
    J Clin Psychiatry; 2012 Jun; 73(6):e757-66. PubMed ID: 22795216
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Long-term safety and efficacy of risperidone for the treatment of disruptive behavior disorders in children with subaverage IQs.
    Turgay A; Binder C; Snyder R; Fisman S
    Pediatrics; 2002 Sep; 110(3):e34. PubMed ID: 12205284
    [TBL] [Abstract][Full Text] [Related]  

  • 14. A randomized placebo-controlled trial of risperidone for the treatment of aggression, agitation, and psychosis of dementia.
    Brodaty H; Ames D; Snowdon J; Woodward M; Kirwan J; Clarnette R; Lee E; Lyons B; Grossman F
    J Clin Psychiatry; 2003 Feb; 64(2):134-43. PubMed ID: 12633121
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The antidepressant effects of risperidone and olanzapine in bipolar disorder.
    McIntyre RS; Mancini DA; Srinivasan J; McCann S; Konarski JZ; Kennedy SH
    Can J Clin Pharmacol; 2004; 11(2):e218-26. PubMed ID: 15520475
    [TBL] [Abstract][Full Text] [Related]  

  • 16. A 6-week, randomized, double-blind, placebo-controlled study of the efficacy and safety of risperidone in adolescents with schizophrenia.
    Haas M; Unis AS; Armenteros J; Copenhaver MD; Quiroz JA; Kushner SF
    J Child Adolesc Psychopharmacol; 2009 Dec; 19(6):611-21. PubMed ID: 20035579
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Evaluation of the efficacy and safety of olanzapine as an adjunctive treatment for anorexia nervosa in adolescent females: a randomized, double-blind, placebo-controlled trial.
    Spettigue W; Buchholz A; Henderson K; Feder S; Moher D; Kourad K; Gaboury I; Norris M; Ledoux S
    BMC Pediatr; 2008 Jan; 8():4. PubMed ID: 18234120
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Double-blind placebo-controlled trial of quetiapine in anorexia nervosa.
    Powers PS; Klabunde M; Kaye W
    Eur Eat Disord Rev; 2012 Jul; 20(4):331-4. PubMed ID: 22535517
    [TBL] [Abstract][Full Text] [Related]  

  • 19. A double-blind, placebo-controlled study of risperidone in adults with autistic disorder and other pervasive developmental disorders.
    McDougle CJ; Holmes JP; Carlson DC; Pelton GH; Cohen DJ; Price LH
    Arch Gen Psychiatry; 1998 Jul; 55(7):633-41. PubMed ID: 9672054
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Tolerability, Safety, and Benefits of Risperidone in Children and Adolescents with Autism: 21-Month Follow-up After 8-Week Placebo-Controlled Trial.
    Aman M; Rettiganti M; Nagaraja HN; Hollway JA; McCracken J; McDougle CJ; Tierney E; Scahill L; Arnold LE; Hellings J; Posey DJ; Swiezy NB; Ghuman J; Grados M; Shah B; Vitiello B
    J Child Adolesc Psychopharmacol; 2015 Aug; 25(6):482-93. PubMed ID: 26262903
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 17.